Aripiprazole and Nexplanon drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Aripiprazole (aripiprazole) and Nexplanon (etonogestrel). Common drug interactions include intermenstrual bleeding among females.

The phase IV clinical study analyzes what interactions people have when they take Aripiprazole and Nexplanon. It is created by eHealthMe based on reports of 49 people who take the same drugs from the FDA, and is updated regularly.

What is Aripiprazole?

Aripiprazole has active ingredients of aripiprazole. It is often used in depression. eHealthMe is studying from 39,143 Aripiprazole users. Check the latest studies of Aripiprazole.

What is Nexplanon?

Nexplanon has active ingredients of etonogestrel. It is often used in birth control. eHealthMe is studying from 46,431 Nexplanon users. Check the latest studies of Nexplanon.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 26, 2026

49 people who take Aripiprazole and Nexplanon together, and have interactions are studied.

Aripiprazole and Nexplanon drug interactions.

What are the common drug interactions of Aripiprazole and Nexplanon, by gender? *:

female:

  1. Intermenstrual bleeding
  2. Abortion spontaneous (naturally occurring miscarriage)
  3. Agitation (state of anxiety or nervous excitement)
  4. Confusional state
  5. Delusion (a false belief or opinion)
  6. Depressive symptom
  7. Drug ineffective
  8. Dystonia (abnormal muscle tone)
  9. Hallucination, visual (seeing things that aren't there)
  10. Impulsive behaviour

male:

n/a

What are the common drug interactions of Aripiprazole and Nexplanon, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Intermenstrual bleeding
  2. Abortion spontaneous (naturally occurring miscarriage)
  3. Maternal exposure during pregnancy (use of substance during pregnancy)
  4. Pregnancy with implant contraceptive
  5. Unintended pregnancy (unwanted pregnancies as well as those that are mistimed)
  6. Pregnancy on contraceptive
  7. Pregnancy with contraceptive device
  8. Metrorrhagia (uterine bleeding at irregular intervals)
  9. Complication of device insertion
  10. Implant site abscess

20-29:

  1. Abortion spontaneous (naturally occurring miscarriage)
  2. Amenorrhoea (absence of a menstrual period in a woman of reproductive age)
  3. Post abortion haemorrhage
  4. Pregnancy with implant contraceptive
  5. Unintended pregnancy (unwanted pregnancies as well as those that are mistimed)
  6. Delirium (wild excitement)
  7. Dysmenorrhoea (painful menstruation)
  8. Headache (pain in head)
  9. Hypomenorrhoea (a diminution of the menstrual flow or a shortening of the duration of menstruation)
  10. Intermenstrual bleeding

30-39:

  1. Affect lability (emotional incontinence)
  2. Agitation (state of anxiety or nervous excitement)
  3. Insomnia (sleeplessness)
  4. Suicidal ideation
  5. Weight increased
  6. Abnormal behaviour
  7. Sleep disorder
  8. Arthralgia (joint pain)
  9. Axillary pain
  10. Carpal tunnel syndrome (nerve compression at wrist results numbness weakness, pain , swelling)

40-49:

n/a

50-59:

n/a

60+:

n/a

What are the existing conditions these people have? *

  1. Bipolar Disorder (mood disorder): 25 people, 51.02%
  2. Seasonal Allergy (allergic condition due to certain season): 24 people, 48.98%
  3. Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 7 people, 14.29%
  4. Negative Thoughts: 7 people, 14.29%
  5. Ill-Defined Disorder: 7 people, 14.29%
  6. Respiration Abnormal (abnormal breathing process): 5 people, 10.20%
  7. Insomnia (sleeplessness): 5 people, 10.20%
  8. Sedation: 4 people, 8.16%
  9. Personality Disorder: 4 people, 8.16%
  10. Major Depression (a mood state that goes well beyond temporarily feeling sad or blue. it is a serious medical illness that affects one's thoughts, feelings): 4 people, 8.16%

* Approximation only. Some reports may have incomplete information.

Do you take Aripiprazole and Nexplanon?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Aripiprazole and Nexplanon:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Aripiprazole:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Nexplanon:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Aripiprazole and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Nexplanon and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on aripiprazole and etonogestrel (the active ingredients of Aripiprazole and Nexplanon, respectively), and Aripiprazole and Nexplanon (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: